Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 3
2012 2
2014 2
2015 1
2016 1
2020 1
2021 2
2022 3
2023 3
2024 7
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.
van der Wilk BJ, Eyck BM, Wijnhoven BPL, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, van Klaveren D, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO Study Group. van der Wilk BJ, et al. Lancet Oncol. 2025 Apr;26(4):425-436. doi: 10.1016/S1470-2045(25)00027-0. Epub 2025 Mar 17. Lancet Oncol. 2025. PMID: 40112851 Clinical Trial.
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, Balduzzi S, Grootscholten C, IJsselsteijn ME, Veenhof AAFA, Hartemink KJ, Vollebergh MA, Jurdi A, Sharma S, Spickard E, Owers EC, Bartels-Rutten A, den Hartog P, de Miranda NFCC, van Leerdam ME, Haanen JBAG, Schumacher TN, Voest EE, Chalabi M. Verschoor YL, et al. Among authors: vollebergh ma. Nat Med. 2024 Feb;30(2):519-530. doi: 10.1038/s41591-023-02758-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191613 Free PMC article. Clinical Trial.
Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid.
van der Sluis K, van Sandick JW, Vollebergh MA, van Dieren JM, Hugen N, Hartemink KJ, Veenhof AAFA, Verhoeven E, van den Berg JG, Snaebjornsson P, Noe M, van Wezel T, Boelens MC, Kodach LL. van der Sluis K, et al. Among authors: vollebergh ma. Oncogene. 2024 Jun;43(24):1877-1882. doi: 10.1038/s41388-024-03034-z. Epub 2024 Apr 23. Oncogene. 2024. PMID: 38654110
Towards Personalization in the Curative Treatment of Gastric Cancer.
Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Slagter AE, et al. Among authors: vollebergh ma. Front Oncol. 2020 Nov 30;10:614907. doi: 10.3389/fonc.2020.614907. eCollection 2020. Front Oncol. 2020. PMID: 33330111 Free PMC article. Review.
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis.
Willemse JRJ, Lambregts DMJ, Balduzzi S, Schats W, Snaebjornsson P, Marchetti S, Vollebergh MA, van Golen LW, Cheung Z, Vogel WV, Bodalal Z, Rostami S, Gerke O, Sivakumaran T, Beets-Tan RGH, Lahaye MJ. Willemse JRJ, et al. Among authors: vollebergh ma. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):225-236. doi: 10.1007/s00259-024-06860-1. Epub 2024 Aug 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 39141069 Free PMC article.
Imaging of cancer of unknown primary: a systematic literature review of the past, present, and future.
Rostami S, Stutterheim HW, Maxouri O, Willemse JRJ, Rodríguez Sánchez DI, Schats W, van Golen LW, Vollebergh MA, Cheung Z, Vogel WV, Marchetti S, Snaebjornsson P, Lahaye MJ, Lambregts DMJ, Bodalal Z, Beets-Tan RGH. Rostami S, et al. Among authors: vollebergh ma. Br J Radiol. 2025 Aug 1;98(1172):1209-1226. doi: 10.1093/bjr/tqaf039. Br J Radiol. 2025. PMID: 40117384 Free PMC article.
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.
Hoeijmakers LL, Rozeman EA, Lopez-Yurda M, Grijpink-Ongering LG, Heeres BC, van de Wiel BA, Flohil C, Sari A, Heijmink SWTPJ, van den Broek D, Broeks A, de Groot JWB, Vollebergh MA, Wilgenhof S, van Thienen JV, Haanen JBAG, Blank CU. Hoeijmakers LL, et al. Among authors: vollebergh ma. Eur J Cancer. 2025 Jun 3;222:115431. doi: 10.1016/j.ejca.2025.115431. Epub 2025 Apr 19. Eur J Cancer. 2025. PMID: 40279684 Clinical Trial.
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
Schipper LJ, Samsom KG, Snaebjornsson P, Battaglia T, Bosch LJW, Lalezari F, Priestley P, Shale C, van den Broek AJ, Jacobs N, Roepman P, van der Hoeven JJM, Steeghs N, Vollebergh MA, Marchetti S, Cuppen E, Meijer GA, Voest EE, Monkhorst K. Schipper LJ, et al. Among authors: vollebergh ma. ESMO Open. 2022 Dec;7(6):100611. doi: 10.1016/j.esmoop.2022.100611. Epub 2022 Dec 1. ESMO Open. 2022. PMID: 36463731 Free PMC article.
Introducing fairness in Norwegian air ambulance base location planning.
Jagtenberg CJ, Vollebergh MAJ, Uleberg O, Røislien J. Jagtenberg CJ, et al. Among authors: vollebergh maj. Scand J Trauma Resusc Emerg Med. 2021 Mar 20;29(1):50. doi: 10.1186/s13049-021-00842-0. Scand J Trauma Resusc Emerg Med. 2021. PMID: 33743747 Free PMC article.
28 results